Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
6
Neutral
5
Bullish
3
Bearish
29
Neutral
5
Bullish
12
Bearish
23
Neutral
0
Bullish
9
Bearish
6
Neutral
5
Bullish
3
Bearish
6
Neutral
5
Bullish
3
Bearish
23
Neutral
0
Bullish
9
Bearish
23
Neutral
0
Bullish
9
Bearish
23
Neutral
0
Bullish
9
Investor Presentation
Q1 FY17
TTK Healthcare Ltd (TTKHLTCARE) is currently trading at 1,016.40 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
TTK Healthcare Limited, part of the TTK Group, offers diversified products across pharmaceuticals, consumer goods, medical devices, and protective devices. The company has wide geographic exposure with exports to regions including the UK, Egypt, and Caribbean countries, showcasing its global reach. TTK Healthcare's strategic moves include divesting non-core segments, such as bulk drugs, and acquiring orthopedic implant facilities to strengthen its medical division. Recent operational changes include recommenced manufacturing at its Virudhunagar facility and product launches to enhance portfolios in various business units. The company's historic product brands like Woodward's Gripewater and recent additions under 'Skore' reflect continued commitment to brand diversity.
Over the past 52 weeks, TTK Healthcare Ltd has traded between a low of ₹737.00 and a high of ₹1,250.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
TTK Healthcare Ltd has a market capitalization of approximately 1,441.72. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
TTK Healthcare Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 19.49 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,441.72 Cr, TTK Healthcare Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
TTK Healthcare Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of TTK Healthcare Ltd is 19.49. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Wipro Enterprises Private Limited will acquire TTK Healthcare’s EVA and Good Home brands along with related assets.
The company said the trading window for designated persons was closed effective July 1, 2026.
The 68th AGM was held on July 26, 2026 and was conducted through VC/OAVM (video conferencing/other audio visual means).
The Board has recommended a final dividend of ₹10 (100%) per equity share, as stated in the provided disclosure.
TTK Healthcare Limited, part of the TTK Group, offers diversified products across pharmaceuticals, consumer goods, medical devices, and protective devices.
The company has wide geographic exposure with exports to regions including the UK, Egypt, and Caribbean countries, showcasing its global reach.
TTK Healthcare's strategic moves include divesting non-core segments, such as bulk drugs, and acquiring orthopedic implant facilities to strengthen its medical division.
Recent operational changes include recommenced manufacturing at its Virudhunagar facility and product launches to enhance portfolios in various business units.
The company's historic product brands like Woodward's Gripewater and recent additions under 'Skore' reflect continued commitment to brand diversity.
Diversified
Diversified
1,436 Cr
Low Risk
19.4
23.5
1.4
1.3
1,250.00
737.00
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
157.25 | 2,689 Cr | 13.00 | 1.30 | 5.41 | 13.37 | 13.98 | 6.18 | ||
1020.30 | 1,442 Cr | 19.49 | 1.30 | 0.98 | 5.89 | 7.50 | 5.57 | ||
270.10 | 946 Cr | 5.11 | 0.29 | 3.15 | 2.77 | 4.15 | 3.92 | ||
997.50 | 599 Cr | 10.67 | 1.70 | 2.51 | 14.67 | 14.12 | 6.88 | ||
71.05 | 210 Cr | 13.09 | 0.97 | 0.00 | 7.80 | 11.93 | 2.48 | ||
3.26 | 185 Cr | 7.03 | 1.05 | 0.31 | 9.08 | 8.93 | 10.77 | ||
234.01 | 183 Cr | 11.63 | 0.91 | 2.78 | 4.48 | 6.15 | 4.72 | ||
| Median: 7 Co. | — | 234.01 | 599 Cr | 11.63 | 1.05 | 2.51 | 7.80 | 8.93 | 5.57 |
